Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Long-term Depression01:05

Long-term Depression

33.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.3K
Long-term Depression01:03

Long-term Depression

3.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.4K
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

40.0K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.0K
Depressants01:28

Depressants

428
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
428
Depression: Overview01:18

Depression: Overview

879
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
879
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

495
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
495

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-specific electrophysiological and behavioral responses to nitrous oxide in a murine model of neuropathic pain.

Biology of sex differences·2026
Same author

Sex and substance use in first episode psychosis: Impact on clinical symptoms, psychosocial functioning and cognitive performance.

Spanish journal of psychiatry and mental health·2026
Same author

Sex differences in the impact of nerve injury on locus coeruleus function and behaviour in mice.

Pain·2026
Same author

Promoting brain health across the lifespan: Socioeconomic burden, global recommendations, and the Spanish national plan.

Neuroscience applied·2026
Same author

From premorbid adjustment dimensions to clinical outcomes: Exploring environmental stress and epigenetic influences on first-episode schizophrenia phenotypes.

Spanish journal of psychiatry and mental health·2025
Same author

Cellular and proteomic differences associated with lithium response in olfactory neuroepithelium cells of bipolar disorder patients.

Molecular medicine (Cambridge, Mass.)·2025

Related Experiment Video

Updated: Jan 31, 2026

The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

39.8K

Monoaminergic system and depression.

L Perez-Caballero1,2,3,4, S Torres-Sanchez2,3,4, C Romero-López-Alberca1,4

  • 1Department of Psychology, University of Cádiz, 11510 Puerto Real, Cádiz, Spain.

Cell and Tissue Research
|January 11, 2019
PubMed
Summary
This summary is machine-generated.

Major depressive disorder affects millions globally. Current antidepressants offer limited efficacy and slow action, prompting research into novel treatments like glutamatergic agents for faster relief.

Keywords:
AntidepressantAugmentationMajor depressionMonoaminesMultitarget agents

More Related Videos

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

22.3K
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

417

Related Experiment Videos

Last Updated: Jan 31, 2026

The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

39.8K
A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

22.3K
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

417

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Major depressive disorder (MDD) is a prevalent and disabling condition affecting approximately 4.7% of the global population.
  • Monoamine reuptake inhibitors are widely used but exhibit limited efficacy and a slow onset of therapeutic action.
  • Existing augmentation strategies and multitarget antidepressants have not fully resolved these limitations.

Purpose of the Study:

  • To review the limitations of current antidepressant therapies.
  • To explore novel pharmacological approaches for managing depression.
  • To highlight the potential of targeting the glutamatergic system for fast-acting antidepressant effects.

Main Methods:

  • Literature review of existing antidepressant treatments and augmentation strategies.
  • Analysis of the monoaminergic hypothesis and its limitations.
  • Exploration of emerging research on non-monoaminergic targets, particularly the glutamatergic system.

Main Results:

  • Monoamine reuptake inhibitors and augmentation therapies show incomplete efficacy and delayed responses in many patients.
  • Multitarget antidepressants offer some improvements but do not consistently provide rapid or sustained relief.
  • Emerging research indicates that targeting the glutamatergic system shows promise for developing fast-acting antidepressant agents.

Conclusions:

  • Current antidepressant treatments face significant challenges in achieving rapid and sustained efficacy for a substantial number of patients with major depressive disorder.
  • Novel therapeutic strategies are crucial to address the unmet needs in depression management.
  • Targeting the glutamatergic system represents a promising new frontier for developing next-generation, fast-acting antidepressants.